Page 194 - 2019_10 resto del Mondo_web

M.M. Gorski et al.
The perils of genetic data sharing with patients may involve ethical concerns, lack of confidence in assessing the causality of identified variants, and the implication of some inherited platelet pathologies with other risks.40 For these reasons, sharing genetic data with patients is still an open issue that requires further discussion.
Acknowledgments
This study was supported by Bayer Hemophilia Award Program (BHAP) 2011- Special Project Award to Flora Peyvandi and by BHAP 2012 - Early Career Award to Luca A. Lotta. We thank Prof. Pier Mannuccio Mannucci for his critical revision of the manuscript.
References
1. Cattaneo M. Inherited platelet-based bleed- ing disorders. J Thromb Haemost. 2003;1 (7):1628-1636.
2. Hayward CP, Rao AK, Cattaneo M. Congenital platelet disorders: overview of their mechanisms, diagnostic evaluation and treatment. Haemophilia. 2006;12(Suppl 3):128-136.
3. Hayward CP, Rivard GE. Quebec platelet disorder. Expert Rev Hematol. 2011;4(2): 137-141.
4. Nurden A, Nurden P. Advances in our under- standing of the molecular basis of disorders of platelet function. J Thromb Haemost. 2011;9 (Suppl 1):76-91.
5. Lotta L, Maino A, Tuana G, et al. Prevalence of disease and relationships between labora- tory phenotype and bleeding severity in platelet primary secretion defects. PLoS One. 2013;8(4):e60396.
6. Rao AK, Jalagadugula G, Sun L. Inherited defects in platelet signaling mechanisms. Semin Thromb Hemost. 2004;30(5):525-535.
7. Quiroga T, Goycoolea M, Panes O, et al. High prevalence of bleeders of unknown cause among patients with inherited muco- cutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica. 2007;92(3):357-365.
8. Cattaneo M. Light transmission aggregome- try and ATP release for the diagnostic assess- ment of platelet function. Sem Thromb Hemost. 2009;35(2):158-167.
9. Pai M, Wang G, Moffat KA, et al. Diagnostic usefulness of a lumi-aggregometer adenosine triphosphate release assay for the assessment of platelet function disorders. Am J Clin Pathol. 2011;136(3):350-358.
10. Cattaneo M. Molecular defects of the platelet P2 receptors. Purinergic Signal. 2011;7(3):333-339.
11. Bastida JM, Lozano ML, Benito R, et al. Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders. Haematologica. 2018;103(1):148-162.
12. Peyvandi F, Hayward CP. Genomic approaches to bleeding disorders. Haemophilia. 2016;22 (Suppl 5):42-45.
13. Simeoni I, Stephens JC, Hu F, et al. A high- throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders. Blood. 2016;127(23):2791-2803.
14. Leinoe E, Zetterberg E, Kinalis S, et al. Application of whole-exome sequencing to direct the specific functional testing and diag- nosis of rare inherited bleeding disorders in patients from the Oresund Region, Scandinavia. Br J Haematol. 2017;179(2): 308-322.
15. Leo VC, Morgan NV, Bem D, et al. Use of next-generation sequencing and candidate gene analysis to identify underlying defects in patients with inherited platelet function disorders. J Thromb Haemost. 2015;13
(4):643-650.
16. Lozano ML, Cook A, Bastida JM, et al. Novel
mutations in RASGRP2, which encodes CalDAG-GEFI, abrogate Rap1 activation, causing platelet dysfunction. Blood. 2016;128(9):1282-1289.
17. Sevivas T, Bastida JM, Paul DS, et al. Identification of two novel mutations in RASGRP2 affecting platelet CalDAG-GEFI expression and function in patients with bleeding diathesis. Platelets. 2018;29(2):192- 195.
18. Maclachlan A, Dolan G, Grimley C, Watson SP, Morgan NV, on behalf of the Uk Gapp Study Group. Whole exome sequencing identifies a mutation in thrombomodulin as the genetic cause of a suspected platelet dis- order in a family with normal platelet func- tion. Platelets. 2017;28(6):611-613.
19. Bariana TK, Ouwehand WH, Guerrero JA, Gomez K. Dawning of the age of genomics for platelet granule disorders: improving insight, diagnosis and management. Br J Haematol. 2017;176(5):705-720.
20. Heremans J, Freson K. High-throughput sequencing for diagnosing platelet disorders: lessons learned from exploring the causes of bleeding disorders. Int J Lab Hematol. 2018;40 (Suppl 1):89-96.
21. Lentaigne C, Freson K, Laffan MA, Turro E, Ouwehand W. Inherited platelet disorders: toward DNA-based diagnosis. Blood. 2016;127(23):2814-2823.
22. Westbury SK, Mumford AD. Genomics of platelet disorders. Haemophilia. 2016;22 (Suppl 5):20-24.
23. Lotta LA, Lombardi R, Mariani M, et al. Platelet reactive conformation and multimer- ic pattern of von Willebrand factor in acquired thrombotic thrombocytopenic pur- pura during acute disease and remission. J Thromb Haemost. 2011;9(9):1744-1751.
24. Tosetto A, Rodeghiero F, Castaman G, et al. A quantitative analysis of bleeding symp- toms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost. 2006;4(4):766-773.
25. Lotta LA, Wang M, Yu J, et al. Identification of genetic risk variants for deep vein throm- bosis by multiplexed next-generation sequencing of 186 hemostatic/pro-inflam- matory genes. BMC Med Genomics. 2012;5(7):1-8.
A, Mannucci PM. Sustained correction of the bleeding time in an afibrinogenaemic patient after infusion of fresh frozen plasma. Br J Haematol. 1992;82(2):388-390.
29. Cattaneo M, Lecchi A, Lombardi R, Gachet C, Zighetti ML. Platelets from a patient het- erozygous for the defect of P2CYC receptors for ADP have a secretion defect despite nor- mal thromboxane A2 production and normal granule stores: further evidence that some cases of platelet 'primary secretion defect' are heterozygous for a defect of P2CYC receptors. Arterioscler Thromb Vasc Biol. 2000;20(11):101-106.
30. Li R, Yu C, Li Y, et al. SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics. 2009;25(15):1966-1967.
31. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recom- mendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-424.
32. Kim MS, Pinto SM, Getnet D, et al. A draft map of the human proteome. Nature. 2014;509(7502):575-581.
33. Huang DW, Sherman BT, Tan Q, et al. DAVID bioinformatics resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 2007;35(Web Server issue):W169-W175.
34. Ye S, Huang Y, Joshi S, et al. Platelet secretion and hemostasis require syntaxin-binding protein STXBP5. J Clin Invest. 2014;124(10): 4517-4528.
35. Zhu Q, Yamakuchi M, Ture S, et al. Syntaxin-binding protein STXBP5 inhibits endothelial exocytosis and promotes platelet secretion. J Clin Invest. 2014;124(10):4503- 4516.
36. Lipschutz JH, Mostov KE. Exocytosis: the many masters of the exocyst. Curr Biol. 2002;12(6):212-214.
37. Schultess J, Danielewski O, Smolenski AP. Rap1GAP2 is a new GTPase-activating pro- tein of Rap1 expressed in human platelets. Blood. 2005;105(8):3185-3192.
38. Shyr C, Tarailo-Graovac M, Gottlieb M, Lee JJ, van KC, Wasserman WW. FLAGS, fre- quently mutated genes in public exomes. BMC Med Genomics. 2014;7(64):1-11
39. Eilbeck K, Quinlan A, Yandell M. Settling the score: variant prioritization and Mendelian disease. Nat Rev Genet. 2017;18(10):599-
26. Cattaneo M, Cerletti C, Harrison P, et al. Recommendations for the standardization
of light transmission aggregometry: a con- 612.
sensus of the Working Party from the Platelet Physiology Subcommittee of SSC/ISTH. J Thromb Haemost. 2013;11 (6):1183-1186.
27. Femia EA, Pugliano M, Podda G, Cattaneo M. Comparison of different procedures to prepare platelet-rich plasma for studies of platelet aggregation by light transmission aggregometry. Platelets. 2012;23(1):7-10.
28. Cattaneo M, Bettega D, Lombardi R, Lecchi
40. Greinacher A, Eekels JJM. Diagnosis of hereditary platelet disorders in the era of next-generation sequencing:"primum non nocere". J Thromb Haemost. 2019; 10.1111/jth.14377
41. Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J. A general frame- work for estimating the relative pathogenici- ty of human genetic variants. Nat Genet. 2014;46(3):310-315.
2090
haematologica | 2019; 104(10)